Search





Search





Markets
/
Stocks
/
mnpr
/

Monopar Therapeutics Inc

MNPR

Add to Watchlist

110.450USD

+0.580+0.53%

Close 07-27 16:00（ET）Quotes delayed by 15 min

739.91MMarket Cap

LossP/E TTM

Monopar Therapeutics Inc

110.450

+0.580+0.53%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-27

Previous score

7.00

Change

The current institutional shareholding score of Monopar Therapeutics Inc is 7.00, ranking 80 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 88.03%, representing a quarter-over-quarter increase of 29.07%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 254.69 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Janus Henderson Investors

1.29M

+9.81%

RA Capital Management, LP

511.21K

Adage Capital Management, L.P.

659.20K

+10.01%

Gem Pharmaceuticals LLC

611.08K

AstraZeneca PLC

387.33K

Saturn V Capital Management LP

155.37K

Adar1 Capital Management LLC

130.00K

+28.75%

BlackRock Institutional Trust Company, N.A.

182.63K

-0.73%

Wellington Management Company, LLP

231.46K